Generate a tailored SOP for Dr. Gabriela Chiosis. Improve your application with a focused, well-structured draft.
Gabriela Chiosis is a prominent researcher at the Sloan Kettering Institute specializing in the biochemical mechanisms underlying diseases related to stress. Her lab, the Chiosis Lab, focuses on developing innovative chemical biology approaches to investigate stressor maladaptation mechanisms. She has pioneered the study of the epichaperome, a distinct and crucial structure involved in cellular stress response and has made significant contributions to understanding the proteome-wide malfunctions resulting from chronic stressors. The lab's research aims to diagnose and treat cellular processes linked to these chronic stressors by developing small molecular chemical toolsets that target the epichaperome. Gabriela received her PhD from Columbia University and has been actively involved in translating her bench research into clinical applications, particularly concerning cancer and neurodegenerative diseases. Under her leadership, the Chiosis Lab engages in projects that explore new therapeutic options based on their findings in epichaperome biology.
Administered through the Gerstner Sloan Kettering (GSK) Graduate School. The program focus is Cancer Biology and includes faculty from the Department of Molecular Pharmacology.